Advanced search
Publication Cover
Leukemia & Lymphoma Volume 65, 2024 - Issue 5
Submit an article Journal homepage
75
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Chimeric antigen receptor T-cells might unmask transdifferentiated histiocytic sarcoma during diffuse large B-cell lymphoma treatment

Curtis Gravenmiera Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USAView further author information
,
Bijal Shahb Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USAView further author information
,
Mohammad Hussainia Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USACorrespondence[email protected]
View further author information
&
Ling Zhanga Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USACorrespondence[email protected]
View further author information
Pages 674-678 | Received 20 Oct 2023, Accepted 27 Dec 2023, Published online: 19 Jan 2024

References

  • Kommalapati A, Tella SH, Durkin M, et al. Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes. Blood. 2018;131(2):265–268. doi:10.1182/blood-2017-10-812495
  • Song SY, Ko YH, Ahn G. Mediastinal germ cell tumor associated with histiocytic sarcoma of spleen: case report of an unusual association. Int J Surg Pathol. 2005;13(3):299–303. doi:10.1177/106689690501300314
  • Xiao W, Amador C, Cook JR, et al. B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy: report from the 2021 SH/EAHP workshop. Am J Clin Pathol. 2023;159(6):522–537. doi:10.1093/ajcp/aqad022
  • Egan C, Lack J, Skarshaug S, et al. The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy. Mod Pathol. 2021;34(2):336–347. doi:10.1038/s41379-020-00673-x
  • Feldman AL, Arber DA, Pittaluga S, et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood. 2008;111(12):5433–5439. doi:10.1182/blood-2007-11-124792
  • Xie H, Ye M, Feng R, et al. Stepwise reprogramming of B cells into macrophages. Cell. 2004;117(5):663–676. doi:10.1016/s0092-8674(04)00419-2
  • Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature. 2007;449(7161):473–477. doi:10.1038/nature06159
  • Stoecker MM, Wang E. Histiocytic/dendritic cell transformation of B-cell neoplasms: pathologic evidence of lineage conversion in differentiated hematolymphoid malignancies. Arch Pathol Lab Med. 2013;137(6):865–870. doi:10.5858/arpa.2012-0104-RS
  • Cimprich KA, Cortez D. ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol. 2008;9(8):616–627. doi:10.1038/nrm2450
  • Borst J, Hendriks J, Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol. 2005;17(3):275–281. doi:10.1016/j.coi.2005.04.004
  • Donati G, Amati B. MYC and therapy resistance in cancer: risks and opportunities. Mol Oncol. 2022;16(21):3828–3854. doi:10.1002/1878-0261.13319
  • Winkelmann M, Rejeski K, Unterrainer M, et al. Transformation of diffuse large B cell lymphoma into dendritic sarcoma under CAR T cell therapy detected on 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2021;48(5):1692–1693. doi:10.1007/s00259-020-05000-9
  • Laurent C, Syrykh C, Hamon M, et al. Resistance of B-cell lymphomas to CAR T-cell therapy is associated with genomic tumor changes which can result in transdifferentiation. Am J Surg Pathol. 2022;46(6):742–753. doi:10.1097/PAS.0000000000001834
  • Kumar J, Al-Kawaaz M, Martin BA, et al. Histiocytic sarcoma with CCND1 gene rearrangement clonally related and transdifferentiated from mantle cell lymphoma. Am J Clin Pathol. 2022;158(4):449–455. doi:10.1093/ajcp/aqac087
  • Zhang Q, Orlando EJ, Wang HY, et al. Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome. Blood. 2020;136(17):1980–1983. doi:10.1182/blood.2020005123

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.